Article
Multiple treatments with human embryonic stem cell-derived mesenchymal progenitor cells preserved fertility and ovarian function of perimenopausal mice undergoing natural aging.
2023-12-04
Abstract excerpt
<title>Abstract</title> <p><bold>Objectives:</bold> There is no approved therapy to preserve ovarian health with aging. To solve this problem, we developed a long-term treatment of human embryonic stem cell-derived mesenchymal progenitor cells (hESC-MPCs) and investigated whether the cells retained the ability to resist ovarian aging, leading to delayed reproductive senescence. <bold>Materials and Methods: </bold...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 7845f073-9895-516a-816e-d9eb2ee17f5e
- DOI
- 10.21203/rs.3.rs-3652097/v1
